Rapid Time to Clinic
Lowest Cost at Every Stage
LAB2LAUNCH
keyboard_arrow_left
Swipe for More
From Lab…
- Rapid production of candidate molecules for lead selection
- Protein function composition improvement
- Protein yield and stability optimization
To Launch
- Production process development and scale-up
- Bulk drug substance for clinical trials in under six months
- Facility capacity of 300 kg per year
LAB2LAUNCH
Regulatory Intelligence
Early Stage Biotechs Rely on iBio’s Regulatory Guidance
- Initial risk assessment in pre-clinical environment
- E-publishing of Pre-IND and IND packages
- iBio and preferred partner CBR deliver support throughout the entire IND process
- Ex-FDA experts provide insider knowledge
- Eliminate the need for additional quality assurance professionals
LAB2LAUNCH
Start Over